Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid

  • Read more about A Study of Amantadine for Cognitive Dysfunction in Patients With Long-Covid

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

  • Read more about Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

Balance Acceptance and Commitment Therapy for Long COVID

  • Read more about Balance Acceptance and Commitment Therapy for Long COVID

Virus and Bronchial Epithelium in Children and the Elderly

  • Read more about Virus and Bronchial Epithelium in Children and the Elderly

Long COVID-19 [11C]CPPC Study

  • Read more about Long COVID-19 [11C]CPPC Study

Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

  • Read more about Evaluation of the Efficacy and Safety of Molnupiravir Treatment in Mild/Moderate Covid-19 Patients.

Thrombohemorrhagic Complications of COVID-19

  • Read more about Thrombohemorrhagic Complications of COVID-19

Hybrid Interactive Avatars for Post-COVID Sufferers

  • Read more about Hybrid Interactive Avatars for Post-COVID Sufferers

Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

  • Read more about Post-trial Access Program of Idursulfase-IT Along With Elaprase in Children With Hunter Syndrome

A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults

  • Read more about A Study to Evealuate Safety and Immunogenicity of TI-0010 SARS-CoV-2 Vaccine in Healthy Adults

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 97
  • Page 98
  • Page 99
  • Page 100
  • Current page 101
  • Page 102
  • Page 103
  • Page 104
  • Page 105
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA